Tompkins Financial’s John Hancock Multifactor Healthcare ETF JHMH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-987
Closed -$43K – 638
2022
Q3
$43K Hold
987
– – 0.01% 347
2022
Q2
$45K Hold
987
– – 0.01% 339
2022
Q1
$49K Hold
987
– – 0.01% 350
2021
Q4
$51K Hold
987
– – 0.01% 223
2021
Q3
$48K Buy
+987
New +$49.1K 0.01% 229
2021
Q1
$44K Hold
987
– – 0.01% 264
2020
Q4
$43K Hold
987
– – 0.01% 256
2020
Q3
$39K Sell
987
-130
-12% -$5.14K 0.01% 259
2020
Q2
$42K Hold
1,117
– – 0.01% 248
2020
Q1
$36K Hold
1,117
– – 0.01% 254
2019
Q4
$42K Hold
1,117
– – 0.01% 268
2019
Q3
$37K Sell
1,117
-100
-8% -$3.37K 0.01% 247
2019
Q2
$42K Hold
1,217
– – 0.01% 243
2019
Q1
$42K Hold
1,217
– – 0.01% 247
2018
Q4
$38K Hold
1,217
– – 0.01% 252
2018
Q3
$44K Sell
1,217
-50
-4% -$1.72K 0.01% 260
2018
Q2
$41K Hold
1,267
– – 0.01% 271
2018
Q1
$39K Hold
1,267
– – 0.01% 261
2017
Q4
$39K Hold
1,267
– – 0.01% 241
2017
Q3
$39K Buy
+1,267
New +$38K 0.01% 240

Tompkins Financial's JHMH Position: Q4 2022 in Review

Tompkins Financial sold out of John Hancock Multifactor Healthcare ETF (JHMH) in Q4 2022, closing a stake of 987 shares — an estimated $43K sold.

Tompkins Financial first reported a position in JHMH in Q3 2017 and held it in 20 quarters. The position peaked at $51K in Q4 2021. 0 funds tracked by Wall St. Rank hold JHMH as of Q4 2022.

  • Tompkins Financial reported no remaining John Hancock Multifactor Healthcare ETF position as of Q4 2022 after selling out during the quarter.
  • Tompkins Financial sold 987 John Hancock Multifactor Healthcare ETF shares in Q4 2022, an estimated $43K.
  • Tompkins Financial first reported a position in John Hancock Multifactor Healthcare ETF in Q3 2017 and held it in 20 quarters.
  • Tompkins Financial's John Hancock Multifactor Healthcare ETF position peaked at $51K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held John Hancock Multifactor Healthcare ETF as of Q4 2022.

Based on Tompkins Financial's 13F filing for Q4 2022, filed 6 Jan 2023.